Skip to main content

Braslyn Ltd.

SEC CIK
0001642355
Latest filing
Feb 14, 2025

Holdings in Q4 2023

Holdings as of Dec 31, 2023, filed Feb 14, 2024. Long positions only.

Institution overview
Positions
3
No filing for Q3 2023
Portfolio value
$186.2M
No filing for Q3 2023
Filed
Feb 14, 2024
SEC

Braslyn Ltd. did not file a 13F for Q3 2023, so these holdings cannot be compared with the previous quarter and changes are not shown.

Holdings of Braslyn Ltd. in Q4 2023
SecurityClassSharesValue% of portfolioShare changeActionHistory
MRTXMirati Therapeutics, Inc.COM3,135,966$184.2M99.0%––History
INSGInseego Corp.COM7,614,830$1.68M0.9%––History
TNGXTango Therapeutics, Inc.COM26,961$266.9K0.1%––History